| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α |
|---|
| Description | A number of 17-phenyl trinor PGF2α derivatives have been approved for the treatment of glaucoma.{8941,9341,8839} Of these, the ones wherein the 13,14-double bond has been hydrogenated retain relatively good potency, but show a significantly reduced incidence of local irritant side effects.{9736} 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2α bears an aromatic ring which is reminiscent of the trifluoromethyl-phenoxy ring of travoprost ((+)-fluprostenol isopropyl ester). As an ocular hypotensive agent, it would be expected that 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2α would act very much like the free acid of latanoprost. |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2α |
|---|
| Gene, Accession, CAS # | CAS: 294856-01-2 |
|---|
| Catalog # | 16895-1 |
|---|
| Price | |
|---|
| Order / More Info | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|